Skip to content Skip to navigation


Fentanyl, carfentanil prompt higher naloxone dosage

October 24, 2016  |  Tom Valentino, Senior Editor
Two expert panels have voted to recommend that the FDA increase the minimum dosage of naloxone in the wake of climbing overdose rates involving fentanyl and carfentanil.

Methadone remains vital in buprenorphine era

October 20, 2016  |  Alison Knopf, Contributing Writer
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.

Hazelden Betty Ford executive will oversee clinical standardization

October 14, 2016  |  Gary A. Enos, Editor
Longtime Hazelden Betty Ford Foundation leader John Driscoll has been named to the organization's new position of senior vice president of recovery services.

Kratom research sorely needed for clinical, policy decisions

October 13, 2016  |  Julie Miller, Editor in Chief
The Drug Enforcement Administration (DEA) has slowed its move to place kratom on its most restrictive scheduling, as members of the research community argue against blocking studies of possible analgesic benefits.

Portman, Ayotte among members of Congress recognized by opioid coalition

September 22, 2016  |  Gary A. Enos, Editor
U.S. Sens. Rob Portman and Kelly Ayotte, both facing high-profile re-election challenges this fall, are among eight members of Congress recognized this week for efforts to combat the opioid epidemic.

Younger adult overdoses on the rise in Virginia

September 21, 2016  |  Tom Valentino, Senior Editor
Adults ages 25 to 44 accounted for more than half of all drug overdose-related deaths in Virginia from 2007 to 2014, according to research published this week.

Alkermes establishes grant program for nonprofits

September 16, 2016  |  Gary A. Enos, Editor
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.

ASAM releases patient guide to opioid addiction treatment

September 2, 2016  |  Gary A. Enos, Editor
Assessment, treatment planning and medical interventions are addressed in the American Society of Addiction Medicine's (ASAM's) opioid treatment guide for patients and families.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

FDA mandates warnings, education on use of opioids with benzodiazepines

September 1, 2016  |  Gary A. Enos, Editor
Based partly on findings of increases in overdoses from concurrent prescribing of opioids and benzodiazepines, the Food and Drug Administration (FDA) is requiring boxed warnings and patient guides for nearly 400 individual drugs.

Researchers to launch human testing of anti-cocaine vaccine

August 9, 2016  |  Gary A. Enos, Editor
Researchers at two New York institutions are recruiting active cocaine users for Phase I testing of an anti-cocaine vaccine that has shown promise in animal research.

Significant prevalence of gabapentin misuse seen in pain patients

August 5, 2016  |  Gary A. Enos, Editor
Data presented this week at a national scientific meeting indicate that a significant number of prescription opioid users are misusing the anti-seizure medication gabapentin.


Subscribe to Medication